verve records - Search News

News

Eli Lilly Buys Verve Therapeutics

Lilly to buy gene-editing partner Verve for up to $1.3 billion in cardiac care push

Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, to boost its pipeline of experimental medicines beyond its blockbuster weight-loss and diabetes drugs.

UPI on MSN · 1d

Eli Lilly Co. to buy gene-editing startup Verve to develop cardiac drugs

Eli Lilly will buy Boston-based Verve Therapeutics, Inc. in a billion dollar deal with plans to advance Verve's new line of experimental cardiac health drugs.

Barron's on MSN · 2d

Eli Lilly’s $1.3 Billion Bid Sends Verve Therapeutics Stock Soaring. What to Know.

Lilly confirmed it would buy a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease.

2don MSN

Why Verve Therapeutics Stock Is Skyrocketing Today

Shares of Verve Therapeutics ( VERV 76.56%) were skyrocketing 75.7% higher as of 10:50 a.m. ET on Tuesday. And for good reason. Eli Lilly ( LLY -0.90%) and Verve Therapeutics announced a "definitive ...

Lock In The 81.5% Run - Initiating Verve With A Sell

Verve Therapeutics remains an early-stage biotech, making the rally purely acquisition-driven, not based on fundamentals.

uDiscoverMusic13d

The Verve’s ‘Urban Hymns’ Is Returning To Vinyl

The Verve’s founder and lead singer, Richard Ashcroft, became a solo act in 2000. He recently released the single “Lover,” ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results